Form D · Biotechnology
ShouTi Inc.
South San Francisco, CA · CIK 0001888886
Offering snapshot reported Jan 10, 2022 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 15, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 10, 2022 | Initial | $6,999,917 | No comparison | 8 | SEC filing |
| Oct 21, 2021 | Initial | $25,999,992 | No comparison | 9 | SEC filing |
| Oct 21, 2021 | Initial | $32,000,640 | No comparison | 6 | SEC filing |
| Oct 21, 2021 | Initial | $100,000,022 | No comparison | 30 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-428629
Source: Form D, filed Jan 10, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Auerbach | Director |
| Ramy Farid | Director |
| Cuiping Gu | Director |
| Jessica Lifton | Director |
| Raymond Stevens | Director |
| Robert Weisskoff | Director |
| Ting Xie | Director |
| Jun Yoon | Director |
| Chen Ming Yu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
611 Gateway Blvd Suite 223
South San Francisco, CA, 94080
South San Francisco, CA, 94080